Segregation analysis of prostate cancer in 1719 white, African-American and Asian-American families in the United States and Canada

Cancer Causes and Control

Volumn 13, Issue 5, 2002, Pages 471-482

  Gong, Gail ^a   Oakley Girvan, Ingrid ^a   Wu, Anna H ^b   Kolonel, Laurence N ^c   John, Esther M ^d   West, Dee W ^d   Felberg, Anna ^a   Gallagher, Richard P ^e   Whittemore, Alice S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d NORTHERN CALIFORNIA CANCER CENTER   (United States)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Dominant inheritance; Prostate cancer; Recessive inheritance; Segregation analysis; X linked inheritance

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASIAN AMERICAN; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CANADA; CANCER INCIDENCE; CAUCASIAN; CONTROLLED STUDY; FAMILY STUDY; GENETIC RISK; HETEROZYGOTE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; NEGRO; PENETRANCE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE; SEGREGATION ANALYSIS; STATISTICAL MODEL; UNITED STATES; X CHROMOSOME LINKAGE; ETHNOLOGY; GENETICS; INCIDENCE; MIDDLE AGED; PEDIGREE; PROSTATE TUMOR; X CHROMOSOME;

ADULT; AGED; ASIAN AMERICANS; CAUCASOID RACE; HUMAN; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGE; NEGROID RACE; PEDIGREE; PROSTATIC NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES; X CHROMOSOME; AFRICAN CONTINENTAL ANCESTRY GROUP; CHROMOSOMES, HUMAN, X; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MIDDLE AGED;

EID: 0035987715     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015755219674     Document Type: Article

References (52)

1. Cancer statistics, 2001
2. An investigation of the familial aspects of cancer of the prostate
3. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy
4. Familial prostatic cancer risk and low testosterone
5. Epidemiologic evidence regarding predisposing factors to prostate cancer
6. Family history and the risk of prostate cancer
7. Familial patterns of prostate cancer: A case-control analysis
8. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands
9. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada
10. Evidence of an X-linked or recessive genetic component to prostate cancer risk
11. Prostate cancer
12. The role of increasing detection in the rising incidence of prostate cancer
13. Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
14. Genetics of prostate cancer: Too many loci, too few genes
15. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
16. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
17. Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival
18. Significance of the cag repeat polymorphism of the androgen receptor gene in prostate cancer progression
19. Evidence for a prostate cancer susceptibility locus on the X chromosome
20. Mendelian inheritance of familial prostate cancer
21. Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance
22. Evidence for autosomal dominant inheritance of prostate cancer
23. Segregation analyses of 1,476 population-based Australian families affected by prostate cancer
24. Major susceptibility locus for prostate cancer on chromosome I suggested by a genome-wide search
25. Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study
26. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43
27. Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer
28. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36
29. A candidate prostate cancer susceptibility gene at chromosome 17p
30. Evidence for a prostate cancer-susceptibility locus on chromosome 20
31. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25
32. Linkage analysis of chromosome 1q markers in 136 prostate cancer families
33. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer
34. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer
35. HPC2 variants and screen-detected prostate cancer
36. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer
37. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada
38. Multi-stage sampling in genetic epidemiology
39. Multistage sampling for disease family registries
40. Multistage sampling designs and estimating equations
41. Tests of hypotheses in overdispersed Poisson regression and other quasi-likelihood models
42. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer
43. Testing covariance structure in multivariate models: Application to family disease data
44. Estimating genetic influence on disease from population-based case-control data: Application to cancers of the breast and ovary
45. Trends in prostate cancer survival in Sweden, 1960 through 1988: Evidence of increasing diagnosis of nonlethal tumors